160 related articles for article (PubMed ID: 22912544)
1. Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology.
Du Y; Cao GW
World J Gastroenterol; 2012 Aug; 18(30):3941-4. PubMed ID: 22912544
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and gene expression parameters predict liver cancer prognosis.
Hao K; Lamb J; Zhang C; Xie T; Wang K; Zhang B; Chudin E; Lee NP; Mao M; Zhong H; Greenawalt D; Ferguson MD; Ng IO; Sham PC; Poon RT; Molony C; Schadt EE; Dai H; Luk JM
BMC Cancer; 2011 Nov; 11():481. PubMed ID: 22070665
[TBL] [Abstract][Full Text] [Related]
3. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
[TBL] [Abstract][Full Text] [Related]
4. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
5. Biology of Hepatocellular Carcinoma.
Critelli RM; De Maria N; Villa E
Dig Dis; 2015 Sep; 33(5):635-41. PubMed ID: 26398186
[TBL] [Abstract][Full Text] [Related]
6. [Genomic prognostic markers in hepatocellular carcinoma].
Alsinet C; Villanueva A
Gastroenterol Hepatol; 2012 Feb; 35(2):94-101. PubMed ID: 22178501
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
8. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
9. Molecular signatures and prognosis of hepatocellular carcinoma.
Hoshida Y
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
[TBL] [Abstract][Full Text] [Related]
10. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
11. Integration of genomic information in the clinical management of HCC.
Quetglas IM; Moeini A; Pinyol R; Llovet JM
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):831-42. PubMed ID: 25260311
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
14. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC).
Pourbagheri-Sigaroodi A; Fallah F; Bashash D; Karimi A
Cell Biochem Funct; 2024 Jan; 42(1):e3913. PubMed ID: 38269520
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
[TBL] [Abstract][Full Text] [Related]
16. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.
Weng L; Du J; Zhou Q; Cheng B; Li J; Zhang D; Ling C
Mol Cancer; 2012 Jun; 11():39. PubMed ID: 22682366
[TBL] [Abstract][Full Text] [Related]
17. Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
Tai CS; Lin YR; Teng TH; Lin PY; Tu SJ; Chou CH; Huang YR; Huang WC; Weng SL; Huang HD; Chen YL; Chen WL
PLoS One; 2017; 12(2):e0171269. PubMed ID: 28158312
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.
Tsuchiya M; Parker JS; Kono H; Matsuda M; Fujii H; Rusyn I
Mol Cancer; 2010 Apr; 9():74. PubMed ID: 20380719
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
20. Gene signatures in the management of hepatocellular carcinoma.
Hoshida Y; Moeini A; Alsinet C; Kojima K; Villanueva A
Semin Oncol; 2012 Aug; 39(4):473-85. PubMed ID: 22846864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
